{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:50:07Z","timestamp":1791557407933,"version":"4.3.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012779","name":"Quebec Network for Drug Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024252","name":"University of Montreal Faculty of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024255","name":"Institut TransMedTech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024353","name":"Association canadienne du m\u00e9dicament g\u00e9n\u00e9rique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biomaterials.2025.123942","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:53:08Z","timestamp":1766422388000},"page":"123942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metabolic microenvironment-forming porous hydrogels for the protection of phenylalanine ammonia-lyase in the intestine"],"prefix":"10.1016","volume":"329","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6120-5362","authenticated-orcid":false,"given":"Sofie","family":"Dhondt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Delbreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7899-9385","authenticated-orcid":false,"given":"Isabelle","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-9730","authenticated-orcid":false,"given":"Fatma","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-3179","authenticated-orcid":false,"given":"Xavier","family":"Banquy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5749-1125","authenticated-orcid":false,"given":"Davide","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123942_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104047","article-title":"THPdb2: compilation of FDA approved therapeutic peptides and proteins","volume":"29","author":"Jain","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2025.123942_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.107909","article-title":"Physicochemical factors of bioprocessing impact the stability of therapeutic proteins","volume":"55","author":"Pandey","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biomaterials.2025.123942_bib3","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.3390\/pharmaceutics14112533","article-title":"Instability challenges and stabilization strategies of pharmaceutical proteins","volume":"14","author":"Akbarian","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123942_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123942_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics13010018","article-title":"Oral delivery of biologics via the intestine","volume":"13","author":"New","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123942_bib6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/mp500809f","article-title":"Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123942_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2018.08.032","article-title":"Oral peptide delivery: translational challenges due to physiological effects","volume":"287","author":"Tyagi","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123942_bib8","series-title":"Purple Book: Fda-Licensed Biological Products","year":"2025"},{"key":"10.1016\/j.biomaterials.2025.123942_bib9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1104\/pp.17.01608","article-title":"Biochemical and structural analysis of substrate specificity of a phenylalanine ammonia-lyase","volume":"176","author":"Jun","year":"2018","journal-title":"Plant Physiol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123942_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of Phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biomaterials.2025.123942_bib12","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.108.4.972","article-title":"National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16\u201318, 2000","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.biomaterials.2025.123942_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biomaterials.2025.123942_bib14","series-title":"Clinical Review Report: Sapropterin Dihydrochloride (Kuvan), Canadian Agency for Drugs and Technologies in Health","year":"2017"},{"key":"10.1016\/j.biomaterials.2025.123942_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s13023-021-01968-1","article-title":"Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial","volume":"16","author":"Muntau","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biomaterials.2025.123942_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(24)01556-3","article-title":"Effects of oral sepiapterin on blood phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial","volume":"404","author":"Muntau","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123942_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(24)01819-1","article-title":"Sepiapterin: a potential new therapy for phenylketonuria","volume":"404","author":"Harding","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123942_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.gimo.2025.102891","article-title":"P047: interim results from the APHENITY extension study: sepiapterin reduces blood Phe with improved dietary Phe tolerance in participants with phenylketonuria","volume":"3","author":"Longo","year":"2025","journal-title":"Genetics in Medicine Open"},{"key":"10.1016\/j.biomaterials.2025.123942_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40259-018-0292-3","article-title":"Pegvaliase: first global approval","volume":"32","author":"Markham","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.biomaterials.2025.123942_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"The influence of phenylalanine intake on phenylketonuria","volume":"262","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123942_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2147\/PPA.S512719","article-title":"Phenylketonuria as an adherence disease","volume":"19","author":"Reach","year":"2025","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.biomaterials.2025.123942_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401353","article-title":"Current advances and material innovations in the search for novel treatments of Phenylketonuria","volume":"13","author":"Delbreil","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2025.123942_bib23","first-page":"1","article-title":"A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in Phenylketonuria, artificial cells, blood substitutes","volume":"23","author":"Chang","year":"1995","journal-title":"Biotechnology"},{"key":"10.1016\/j.biomaterials.2025.123942_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-5793(85)80219-2","article-title":"Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria","volume":"180","author":"Bourget","year":"1985","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.biomaterials.2025.123942_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-291X(86)80349-7","article-title":"Entrapment of phenylalanine ammonia-lyase in silk fibroin for protection from proteolytic attack","volume":"141","author":"Inoue","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biomaterials.2025.123942_bib26","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1021\/acs.molpharmaceut.2c00512","article-title":"A silk-based platform to stabilize phenylalanine ammonia-lyase for orally administered enzyme replacement therapy","volume":"19","author":"d'Amone","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123942_bib27","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1021\/acs.jafc.7b00672","article-title":"Enzyme shielding in a large mesoporous hollow Silica Shell for improved recycling and stability based on CaCO3 microtemplates and biomimetic silicification","volume":"65","author":"Cui","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biomaterials.2025.123942_bib28","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijbiomac.2017.02.059","article-title":"Mesoporous phenylalanine ammonia lyase microspheres with improved stability through calcium carbonate templating","volume":"98","author":"Cui","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/acs.jafc.6b05003","article-title":"Encapsulation of spherical cross-linked phenylalanine ammonia lyase aggregates in mesoporous Biosilica","volume":"65","author":"Cui","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biomaterials.2025.123942_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2009.09.002","article-title":"Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria","volume":"99","author":"Kang","year":"2010","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib31","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41598-020-60463-y","article-title":"A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study","volume":"10","author":"Pereira de Sousa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2025.123942_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijbiomac.2020.10.218","article-title":"Paper-based biosensor based on phenylalnine ammonia lyase hybrid nanoflowers for urinary phenylalanine measurement","volume":"166","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122718","article-title":"Biomedical applications of functional hydrogels: innovative developments, relevant clinical trials and advanced products","volume":"312","author":"Z\u00f6ller","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123942_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1208\/s12249-024-02786-x","article-title":"A comprehensive review of Hydrogel-based drug delivery systems: classification, properties, recent trends, and applications","volume":"25","author":"Hameed","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biomaterials.2025.123942_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122441","article-title":"In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model","volume":"630","author":"Jannin","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123942_bib36","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3390\/pharmaceutics15112576","article-title":"In vivo evaluation of a gastro-resistant enprotect\u00ae capsule under postprandial conditions","volume":"15","author":"Grimm","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123942_bib37","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3390\/pharmaceutics14101999","article-title":"In vivo evaluation of a gastro-resistant HPMC-based \u201cNext Generation Enteric\u201d capsule","volume":"14","author":"Rump","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123942_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/acsbiomedchemau.3c00001","article-title":"Template-based porous hydrogel microparticles as carriers for therapeutic proteins","volume":"3","author":"Delbreil","year":"2023","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.biomaterials.2025.123942_bib39","first-page":"e776","article-title":"Anti-erosive effect of calcium carbonate suspensions","volume":"10","author":"Scandiffio","year":"2018","journal-title":"J Clin Exp Dent"},{"key":"10.1016\/j.biomaterials.2025.123942_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202106061","article-title":"Superswelling microneedle arrays for dermal interstitial fluid (Prote)Omics","volume":"31","author":"Laszlo","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123942_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102070","article-title":"A naked eye-invisible ratiometric fluorescent microneedle tattoo for real-time monitoring of inflammatory skin conditions","volume":"11","author":"Babity","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2025.123942_bib42","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1021\/acs.analchem.4c06519","article-title":"Rational design of a new class of versatile enzyme-based biosensors","volume":"97","author":"Pei","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biomaterials.2025.123942_bib43","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1021\/acs.joc.4c02539","article-title":"A microwave-assisted method for the synthesis of symmetrical and unsymmetrical cyanine dyes","volume":"90","author":"Babity","year":"2025","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biomaterials.2025.123942_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3011.1985.tb02155.x","article-title":"The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans","volume":"25","author":"Birk","year":"1985","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.biomaterials.2025.123942_bib45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biomaterials.2025.123942_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2025.123942_bib47","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/elps.200600807","article-title":"Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation","volume":"28","author":"Zheng","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.biomaterials.2025.123942_bib48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/gels10070422","article-title":"Fabrication and characterization of porous PEGDA hydrogels for articular cartilage regeneration","volume":"10","author":"Gonella","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.biomaterials.2025.123942_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1163\/156856208X393464","article-title":"Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption","volume":"20","author":"Peppas","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.biomaterials.2025.123942_bib50","article-title":"Tailoring the swelling-shrinkable behavior of hydrogels for biomedical applications","volume":"10","author":"Feng","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2025.123942_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pol.20190267","article-title":"Investigation of the swelling behavior of hydrogels derived from high-molecular-weight poly(2-ethyl-2-oxazoline)","volume":"58","author":"Segiet","year":"2020","journal-title":"J. Polym. Sci."},{"key":"10.1016\/j.biomaterials.2025.123942_bib52","unstructured":"Torpac Inc, Capsule size chart, (n.d.). https:\/\/www.torpac.com\/Reference\/Torpac%20Size%20Chart.pdf (accessed July 3, 2025)."},{"key":"10.1016\/j.biomaterials.2025.123942_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2010.01.001","article-title":"Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imagining","volume":"388","author":"Saphier","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123942_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2214\/ajr.157.4.1892032","article-title":"The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers","volume":"157","author":"Ros","year":"1991","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202301975","article-title":"Colonic delivery of aqueous suspensions using 3D printed capsules","volume":"9","author":"Green Buzhor","year":"2024","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810324","article-title":"Changes in the mechanical properties of alginate-gelatin hydrogels with the addition of Pygeum africanum with potential application in urology","volume":"23","author":"Kurowiak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123942_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.device.2023.100053","article-title":"Theranostic gastrointestinal residence systems","volume":"1","author":"Ying","year":"2023","journal-title":"Device"},{"key":"10.1016\/j.biomaterials.2025.123942_bib58","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/polym15102341","article-title":"Additive manufacturing and physicomechanical characteristics of PEGDA hydrogels: recent advances and perspective for tissue engineering","volume":"15","author":"Hakim Khalili","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.biomaterials.2025.123942_bib59","unstructured":"USP, the Dissolution Procedure - Development and Validation <1092>, in: USP-NF, Rockville, MD, n.d."},{"key":"10.1016\/j.biomaterials.2025.123942_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5056\/jnm.2014.20.2.265","article-title":"How to assess regional and whole gut transit time with wireless motility capsule","volume":"20","author":"Lee","year":"2014","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.biomaterials.2025.123942_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117758","article-title":"Swelling of high acyl gellan gum hydrogel: characterization of network strengthening and slower release","volume":"259","author":"Kanyuck","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biomaterials.2025.123942_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105689","article-title":"Structural characterization and developability assessment of sustained release hydrogels for rapid implementation during preclinical studies","volume":"158","author":"Agarwal","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.biomaterials.2025.123942_bib63","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/pharmaceutics15041039","article-title":"Influence of PEGDA molecular weight and concentration on the in vitro release of the model protein BSA\u2013FITC from photo crosslinked systems","volume":"15","author":"Rekowska","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123942_bib64","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/mabi.201500245","article-title":"Long-term controlled protein release from Poly(Ethylene glycol) hydrogels by modulating mesh size and degradation","volume":"15","author":"Tong","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biomaterials.2025.123942_bib65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jbm.a.32134","article-title":"Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function","volume":"90","author":"Weber","year":"2009","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.biomaterials.2025.123942_bib66","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1021\/acs.macromol.9b00753","article-title":"A multiscale model for solute diffusion in hydrogels","volume":"52","author":"Axpe","year":"2019","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2025.123942_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/ph15010056","article-title":"Adsorption and sustained delivery of small molecules from nanosilicate hydrogel composites","volume":"15","author":"Stealey","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biomaterials.2025.123942_bib68","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.3390\/molecules28155931","article-title":"Diffusion-limited processes in hydrogels with chosen applications from drug delivery to electronic components","volume":"28","author":"Lavrentev","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2025.123942_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2015.05.006","article-title":"Stabilization of proteins in solid form","volume":"93","author":"Cicerone","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123942_bib70","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/acs.biochem.2c00692","article-title":"How sugars protect dry protein structure","volume":"62","author":"Brom","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2025.123942_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2017.01.024","article-title":"How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions","volume":"114","author":"Mensink","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2025.123942_bib72","first-page":"1007","article-title":"Extraordinary stability of enzymes dried in trehalose: simplified molecular biology","volume":"10","author":"Cola\u00e7o","year":"1992","journal-title":"Biotechnology"},{"key":"10.1016\/j.biomaterials.2025.123942_bib73","unstructured":"Reagents, Simulated intestinal fluid TS, in: United States Pharmacopeia, USP-NF, Rockville, MD, n.d. https:\/\/doi.usp.org\/USPNF\/USPNF_XR3188_01_01.html (accessed September 7, 2025)."},{"key":"10.1016\/j.biomaterials.2025.123942_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1897","article-title":"Noncovalent PEGylation of protein and peptide therapeutics","volume":"15","author":"Andrianov","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbpa.2016.08.006","article-title":"How PEGylation influences protein conformational stability","volume":"34","author":"Lawrence","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2025.123942_bib76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.15171\/apb.2016.043","article-title":"PEGylated human serum albumin: review of PEGylation, purification and characterization methods","volume":"6","author":"Akbarzadehlaleh","year":"2016","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.biomaterials.2025.123942_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173269","article-title":"Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"12","author":"Bell","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2025.123942_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2011.07.014","article-title":"Aprotinin and similar protease inhibitors as drugs against influenza","volume":"92","author":"Zhirnov","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2025.123942_bib79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejpb.2020.06.011","article-title":"Multidimensional analysis of human intestinal fluid composition","volume":"153","author":"Pyper","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2025.123942_bib80","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/adhm.201500334","article-title":"Covalent incorporation of Trehalose within hydrogels for enhanced long-term functional stability and controlled release of biomacromolecules","volume":"4","author":"O'Shea","year":"2015","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2025.123942_bib81","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/bm4003046","article-title":"Trehalose glycopolymers as excipients for protein stabilization","volume":"14","author":"Lee","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2025.123942_bib82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/ten.teb.2012.0458","article-title":"Protein\u2013hydrogel interactions in tissue engineering: mechanisms and applications","volume":"19","author":"Zustiak","year":"2013","journal-title":"Tissue Eng., Part B"},{"key":"10.1016\/j.biomaterials.2025.123942_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125593","article-title":"Acidification of phosphate buffered saline","volume":"676","author":"Vesel\u00fd","year":"2025","journal-title":"Int. J. Pharm."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225008622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225008622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:56:32Z","timestamp":1781686592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225008622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":83,"alternative-id":["S0142961225008622"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123942","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic microenvironment-forming porous hydrogels for the protection of phenylalanine ammonia-lyase in the intestine","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123942"}}